Roquette Launches New Pharma Innovation Center in Latin America
Roquette Opens State-of-the-Art Pharmaceutical Innovation Center in São Paulo to Drive Latin American Healthcare Solutions Roquette, a global leader in plant-based ingredients and pharmaceutical excipients serving the health, nutrition, and…
EMD Serono Strikes Landmark Deal with U.S. to Broaden IVF Therapy Access
EMD Serono Partners with U.S. Government to Expand Access to IVF Therapies for Millions of Americans EMD Serono, the healthcare division of Merck KGaA, Darmstadt, Germany, operating in the United…
ME Therapeutics Licenses CD22 Nanobody to Advance In Vivo CAR Therapy Program
The agreement strengthens ME Therapeutics’ next-generation in vivo CAR cell therapy platform, expanding its pipeline targeting B-cell malignancies through innovative nanobody-based technologies. ME Therapeutics Holdings Inc. (“ME Therapeutics” or the…
FDA Grants Revolution Medicines Priority Voucher for Daraxonrasib (RMC-6236)
Revolution Medicines Receives FDA Priority Voucher for Daraxonrasib (RMC-6236) Under Commissioner’s National Priority Voucher Pilot Program Revolution Medicines Receives FDA Priority Voucher for Daraxonrasib (RMC-6236) Medicines, Inc. (Nasdaq: RVMD), a…
Traditional Medicine in Focus at World Health Summit 2025
raditional Medicine Gains Prominence at World Health Summit 2025 For the first time in its history, the World Health Summit in 2025 highlighted traditional medicine as a core topic, with…
Grifols Opens New U.S. Diagnostic Facility in San Diego
Grifols Strengthens U.S. Diagnostic Manufacturing with New San Diego Facility Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global healthcare company specializing in plasma-derived medicines and innovative diagnostic solutions,…
Taiho Pharma Licenses PI3Kα Inhibitor Risovalisib to Haihe Biopharma
Taiho Pharma and Haihe Biopharma Form Exclusive Japanese Partnership for PI3Kα Inhibitor Risovalisib Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Haihe Biopharma Co., Ltd. (“Haihe”) today announced the signing of an…
Veradermics Raises $150M Series C for Hair Regrowth Pill
Veradermics Secures $150M Series C to Advance Oral Hair Regrowth Therapy Connecticut-based biotech Veradermics has raised $150 million in an oversubscribed Series C funding round to advance its oral hair…
Sanofi, EVOQ Partner in $500M Autoimmune Deal
Sanofi and EVOQ Therapeutics Form $500 Million Partnership to Advance Autoimmune Therapies Sanofi, a global pharmaceutical giant, has entered into a strategic collaboration with EVOQ Therapeutics, a clinical-stage biotechnology company,…
FDA Orphan Drug Chief Departs Amid IRA Exemption Launch
FDA’s Orphan Drug Leadership Shifts Amid Policy Changes and Department-Wide Shakeups Sandra Retzky, formerly the top orphan drug regulator at the FDA, is no longer serving as director of the…
Bayer Foundation Honors Chemist Lutz Ackermann with Hansen Family Award
Chemist Lutz Ackermann Honored With Bayer Foundation’s Hansen Family Award; Four Young Researchers Receive Early Excellence in Science Awards Georg-August University Göttingen chemist Prof. Dr. Lutz Ackermann has been awarded…
CVS Health Expands Access to Affordable Fertility Care
CVS Health Expands Access to Affordable Fertility Treatments Nationwide CVS Health (NYSE: CVS) has announced a major step toward improving access to fertility care and making fertility treatments more affordable…